FDA requires more time to review Moderna's COVID-19 vaccine for adolescents

Moderna has been told that the US FDA will require additional time to complete the assessment of its COVID-19 vaccine, for use in adolescents between the age group 12 to 17 years.

Highlights

• FDA will require additional time for assessing Moderna&r...